Georgakis et al. discovered that higher MCP-1 levels were related to an increased risk of cardioembolic arterial thrombosis in stroke, as well as mortality (Georgakis et al., 2019a; Georgakis et al., 2019b; Georgakis et al., 2021). The gene discussed is CCL2; the disease is Stroke.